Moderna CEO: Cautiously Optimistic on Flu Vaccine Approval

Moderna's CEO, Stéphane Bancel, expressed cautious optimism regarding the potential approval of the company's flu vaccine following a positive recommendation from the FDA advisory committee. This development could significantly enhance flu prevention measures, especially in light of the ongoing global health challenges. Bancel's optimism suggests that Moderna might soon join the ranks of major players in flu vaccine production, potentially improving public health outcomes. For more details, check out the Bloomberg report.